Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Identification of Biomarkers Sensitive to Disease Progression in Patients With Mild Cognitive Impairment: a Two-part Clinical Study. PartA: Multisite MRI Acquisition, Protocol Harmonization. PartB: Identification of Biomarkers Sensitive to Disease Progression in Patients With Mild Cognitive Impairment: a Clinical Study

NCT01425957 is registered in ClinicalTrials.gov with Qualissima as lead sponsor.

NCT NCT01425957
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01425957 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Identification of Biomarkers Sensitive to Disease Progression in Patients With Mild Cognitive Impairment: a Two-part Clinical Study. PartA: Multisite MRI Acquisition, Protocol Harmonization. PartB: Identification of Biomarkers Sensitive to Disease Progression in Patients With Mild Cognitive Impairment: a Clinical Study
Lead sponsor
Qualissima
Phase
Not applicable
Overall status
Completed
Start date
December 31, 2011
Completion date
October 31, 2015
Enrollment
229 (actual)
Sites
13

Conditions

As the registry lists them; a condition with its own page is linked.

mild cognitive impairment